ICHOR Vascular

ICHOR Vascular, Inc., a start-up firm focused on the treatment of Peripheral Arterial Disease (PAD) and Limb Ischemias, partnered with NAMSA for the development of the ICHOR Panacea Vascular Embolectomy Catheter System. Operating as a virtual start-up, ICHOR was tasked with the challenge of bringing a 510(k) device to the U.S. marketplace with limited development and regulatory knowledge, restricted resources and a desire to make a timely exit following clearance.

ICHOR, by applying NAMSA’s APEX PROGRAM (formerly known as NAMSA’s MRO® Approach) throughout the development continuum, achieved a 30 percent savings in timelines while also shaving off $26M in costs throughout the development lifecycle.

NAMSA MRO Program: Advancing Patient Outcomes for PAD

Watch this video on YouTube

Let’s Talk About Your Project

Ask a question or request a meeting with a NAMSA expert to discuss your specific project. We will follow up as quickly as possible. Also, please tell us how you heard about NAMSA.

First Name*

Last Name/Surname*

Business Email*

Company*

Where Are You Based?*

Location of Company Office You Work At/Report To*

How can we help?

By choosing to submit your information to contact NAMSA, you are providing NAMSA consent to process and store your information on the NAMSA Network. At any time, you can submit a request to withdraw your consent for the use of information provided by you. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.